{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:24:33Z","timestamp":1790411073780,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81000544"],"award-info":[{"award-number":["81000544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171209"],"award-info":[{"award-number":["81171209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Natural Science Foundation, China","award":["ZR2010HQ004"],"award-info":[{"award-number":["ZR2010HQ004"]}]},{"name":"Shandong Provincial Natural Science Foundation, China","award":["ZR2011HZ001"],"award-info":[{"award-number":["ZR2011HZ001"]}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02018"],"award-info":[{"award-number":["2011WSA02018"]}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02020"],"award-info":[{"award-number":["2011WSA02020"]}]},{"name":"Shandong Provincial Outstanding Medical Academic Professional Program"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jns.2013.05.029","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T11:55:25Z","timestamp":1371210925000},"page":"4-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Role of the mTOR signaling pathway in epilepsy"],"prefix":"10.1016","volume":"332","author":[{"given":"Xiang-Fei","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.05.029_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2013.05.029_bb0010","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2013.05.029_bb0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12\u2013rapamycin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2013.05.029_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3858\/emm.2011.43.5.032","article-title":"Frontier of epilepsy research \u2014 mTOR signaling pathway","volume":"43","author":"Cho","year":"2011","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4161\/cc.11.2.19022","article-title":"Deconvoluting mTOR biology","volume":"11","author":"Weber","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jns.2013.05.029_bb0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008771","article-title":"mTOR-dependent cell survival mechanisms","volume":"4","author":"Hung","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2013.05.029_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1467-789X.2012.01038.x","article-title":"mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases","volume":"13","author":"Yang","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.jns.2013.05.029_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm3522","article-title":"Amino acid signalling upstream of mTOR","volume":"14","author":"Jewell","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jns.2013.05.029_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jns.2013.05.029_bb0055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.901101","article-title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth","volume":"15","author":"Gao","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.jns.2013.05.029_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/ddq491","article-title":"Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex","volume":"20","author":"Zeng","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.011","article-title":"A role for the mTOR pathway in surface expression of AMPA receptors","volume":"401","author":"Wang","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2013.05.029_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1126\/science.1131693","article-title":"Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites","volume":"314","author":"Raab-Graham","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jns.2013.05.029_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1073\/pnas.012605299","article-title":"A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus","volume":"99","author":"Tang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2013.05.029_bb0090","doi-asserted-by":"crossref","first-page":"18802","DOI":"10.1074\/jbc.M512524200","article-title":"Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons","volume":"281","author":"Gong","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2013.05.029_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:34:3:205","article-title":"The growing role of mTOR in neuronal development and plasticity","volume":"34","author":"Jaworski","year":"2006","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jns.2013.05.029_bb0100","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1523\/JNEUROSCI.1739-04.2004","article-title":"BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development","volume":"24","author":"Schratt","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0105","doi-asserted-by":"crossref","first-page":"18543","DOI":"10.1074\/jbc.M414112200","article-title":"Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2013.05.029_bb0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0896-6273(01)00551-7","article-title":"Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation","volume":"32","author":"Campbell","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2013.05.029_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","article-title":"Tsc2-Rheb signaling regulates EphA-mediated axon guidance","volume":"13","author":"Nie","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0120","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","article-title":"Control of dendritic arborization by the phosphoinositide-3\u2032-kinase-Akt-mammalian target of rapamycin pathway","volume":"25","author":"Jaworski","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","article-title":"Role of mTOR in physiology and pathology of the nervous system","volume":"1784","author":"Swiech","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2013.05.029_bb0130","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1210\/en.2009-0096","article-title":"The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system","volume":"150","author":"Roa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jns.2013.05.029_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2008.08.013","article-title":"Sex steroid control of hypothalamic Kiss1 expression in sheep and rodents: comparative aspects","volume":"30","author":"Smith","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.jns.2013.05.029_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cmet.2009.03.005","article-title":"Critical role for hypothalamic mTOR activity in energy balance","volume":"9","author":"Mori","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jns.2013.05.029_bb0145","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1523\/JNEUROSCI.5482-09.2010","article-title":"Mammalian target of rapamycin signaling modulates photic entrainment of the suprachiasmatic circadian clock","volume":"30","author":"Cao","year":"2010","journal-title":"J Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2013.05.029_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14767058.2012.663176","article-title":"Autophagy in hypoxia\u2013ischemia induced brain injury","volume":"25","author":"Balduini","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0155","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbrc.2010.12.085","article-title":"PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway","volume":"404","author":"Shi","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jns.2013.05.029_bb0160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.expneurol.2011.11.046","article-title":"Mammalian target of rapamycin (mTOR) inhibition reduces cerebral vasospasm following a subarachnoid hemorrhage injury in canines","volume":"233","author":"Zhang","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0165","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/neu.2011.1919","article-title":"Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice","volume":"29","author":"Sekiguchi","year":"2012","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jns.2013.05.029_bb0170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/156720211798120990","article-title":"Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia","volume":"8","author":"Shang","year":"2011","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.jns.2013.05.029_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbpb.2012.04.009","article-title":"Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling","volume":"163","author":"Sheng","year":"2012","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1016\/j.jns.2013.05.029_bb0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.expneurol.2011.11.018","article-title":"Exercise modulates microRNAs that affect the PTEN\/mTOR pathway in rats after spinal cord injury","volume":"233","author":"Liu","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature10594","article-title":"Sustained axon regeneration induced by co-deletion of PTEN and SOCS3","volume":"480","author":"Sun","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jns.2013.05.029_bb0190","doi-asserted-by":"crossref","first-page":"e30012","DOI":"10.1371\/journal.pone.0030012","article-title":"Systemic bisperoxovanadium activates Akt\/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury","volume":"7","author":"Walker","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2013.05.029_bb0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ceb.2008.12.013","article-title":"Tubers and tumors: rapamycin therapy for benign and malignant tumors","volume":"21","author":"Plas","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jns.2013.05.029_bb0200","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2013.05.029_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2013.03.002","article-title":"Long-term effect of everolimus on epilepsy and growth in children under 3years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","author":"Kotulska","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/cc.8.3.7555","article-title":"PI3K\/mTORC1 activation in hamartoma syndromes: therapeutic prospects","volume":"8","author":"Krymskaya","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jns.2013.05.029_bb0220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jns.2013.05.029_bb0225","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jns.2013.05.029_bb0230","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2013.05.029_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yapd.2010.08.003","article-title":"Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders","volume":"57","author":"Freeman","year":"2010","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.jns.2013.05.029_bb0240","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1528-1167.2011.02981.x","article-title":"The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway","volume":"52","author":"McDaniel","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0245","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/0008-5472.CAN-08-2367","article-title":"Curcumin disrupts the Mammalian target of rapamycin-raptor complex","volume":"69","author":"Beevers","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jns.2013.05.029_bb0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.yebeh.2008.11.011","article-title":"Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis","volume":"14","author":"Jyoti","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jns.2013.05.029_bb0255","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1073\/pnas.0610068104","article-title":"Resveratrol stimulates AMP kinase activity in neurons","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2013.05.029_bb0260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BJ20070236","article-title":"Resveratrol is a class IA phosphoinositide 3-kinase inhibitor","volume":"406","author":"Frojdo","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.jns.2013.05.029_bb0265","doi-asserted-by":"crossref","first-page":"36387","DOI":"10.1074\/jbc.M110.169284","article-title":"Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR","volume":"285","author":"Liu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2013.05.029_bb0270","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1528-1167.2012.03674.x","article-title":"Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats","volume":"53","author":"Chachua","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jns.2013.05.029_bb0280","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0285","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1600-6143.2008.02267.x","article-title":"Sirolimus may reduce fertility in male renal transplant recipients","volume":"8","author":"Zuber","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jns.2013.05.029_bb0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.jns.2013.05.029_bb0295","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.transproceed.2011.05.001","article-title":"Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens","volume":"43","author":"Gyurus","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jns.2013.05.029_bb0300","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jcmm.12044","article-title":"Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients","volume":"17","author":"Lopez","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/07853890.2012.663926","article-title":"Antihypertensive effects of bioactive tripeptides \u2014 a random effects meta-analysis","volume":"45","author":"Turpeinen","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0310","doi-asserted-by":"crossref","DOI":"10.1517\/17460441.2013.800479","article-title":"Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment","author":"Lv","year":"2013","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.jns.2013.05.029_bb0315","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jns.2013.05.029_bb0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ng0992-37","article-title":"Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease","volume":"2","author":"Kandt","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0325","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","article-title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products","volume":"7","author":"van Slegtenhorst","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/hmg\/dds414","article-title":"Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex","volume":"22","author":"Carson","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0335","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.93.24.14152","article-title":"Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology","volume":"93","author":"Crino","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2013.05.029_bb0340","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00247-008-0832-y","article-title":"The pathogenesis and imaging of the tuberous sclerosis complex","volume":"38","author":"Baskin","year":"2008","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jns.2013.05.029_bb0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.01270.x","article-title":"Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation","volume":"49","author":"Wong","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0350","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1528-1157.2000.tb00327.x","article-title":"Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome","volume":"41","author":"Koh","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0355","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1528-1167.2007.01117.x","article-title":"Epilepsy surgery in tuberous sclerosis: a systematic review","volume":"48","author":"Jansen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0360","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0365","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1528-1167.2008.01814.x","article-title":"Are cortical tubers epileptogenic? Evidence from electrocorticography","volume":"50","author":"Major","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0370","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0375","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2012.05.015","article-title":"From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches","volume":"68","author":"Ehninger","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2013.05.029_bb0385","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0390","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/era.11.93","article-title":"Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis","volume":"11","author":"Franz","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jns.2013.05.029_bb0395","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0400","doi-asserted-by":"crossref","first-page":"e57445","DOI":"10.1371\/journal.pone.0057445","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2013.05.029_bb0405","article-title":"Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations","author":"Jozwiak","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0410","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1093\/hmg\/ddr393","article-title":"Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex","volume":"20","author":"Anderl","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0415","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yebeh.2012.12.035","article-title":"Focal cortical dysplasia is more common in boys than in girls","volume":"27","author":"Ortiz-Gonzalez","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jns.2013.05.029_bb0420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Blumcke","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20211","article-title":"mTOR cascade activation distinguishes tubers from focal cortical dysplasia","volume":"56","author":"Baybis","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0430","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2007.00059.x","article-title":"Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells","volume":"17","author":"Schick","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2013.05.029_bb0435","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.20949","article-title":"Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia","volume":"60","author":"Ljungberg","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0440","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/9780470994030.ch18","article-title":"Focal brain malformations: a spectrum of disorders along the mTOR cascade","volume":"288","author":"Crino","year":"2007","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.jns.2013.05.029_bb0445","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0450","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jns.2013.05.029_bb0455","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1073\/pnas.2132711100","article-title":"mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo","volume":"100","author":"Kwon","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2013.05.029_bb0460","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1528-1167.2011.03280.x","article-title":"Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice","volume":"52","author":"Sunnen","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0465","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0470","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","article-title":"Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2013.05.029_bb0475","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1358\/dnp.2007.20.8.1157618","article-title":"The mTOR pathway as a potential target for the development of therapies against neurological disease","volume":"20","author":"Zemke","year":"2007","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.jns.2013.05.029_bb0480","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2008.07.022","article-title":"Protective role of autophagy in neonatal hypoxia\u2013ischemia induced brain injury","volume":"32","author":"Carloni","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2013.05.029_bb0485","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nbd.2006.12.003","article-title":"Rapamycin is a neuroprotective treatment for traumatic brain injury","volume":"26","author":"Erlich","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2013.05.029_bb0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.WNP.0000149893.12678.44","article-title":"Pathogenesis of infantile spasms: a model based on developmental desynchronization","volume":"22","author":"Frost","year":"2005","journal-title":"J Clin Neurophysiol"},{"issue":"Suppl. 9","key":"10.1016\/j.jns.2013.05.029_bb0495","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2009.02289.x","article-title":"Focal brain malformations: seizures, signaling, sequencing","volume":"50","author":"Crino","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0500","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1440-1789.2009.01018.x","article-title":"Increased frequency of distinct TSC2 allelic variants in focal cortical dysplasias with balloon cells and mineralization","volume":"29","author":"Schonberger","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2013.05.029_bb0505","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","article-title":"Early control of seizures improves long-term outcome in children with tuberous sclerosis complex","volume":"14","author":"Bombardieri","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jns.2013.05.029_bb0510","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0515","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2010.02695.x","article-title":"The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification","volume":"51","author":"Osborne","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl. 10","key":"10.1016\/j.jns.2013.05.029_bb0520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1167.2005.00353.x","article-title":"Neurocutaneous syndromes and epilepsy \u2014 issues in diagnosis and management","volume":"46","author":"Cross","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0525","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.seizure.2007.11.001","article-title":"Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: report of two cases","volume":"17","author":"Bastos","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2013.05.029_bb0530","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1528-1167.2011.03220.x","article-title":"Validation of the rat model of cryptogenic infantile spasms","volume":"52","author":"Chachua","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0535","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nbd.2009.11.011","article-title":"A model of symptomatic infantile spasms syndrome","volume":"37","author":"Scantlebury","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2013.05.029_bb0540","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4161\/cc.9.12.11866","article-title":"Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?","volume":"9","author":"Zeng","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jns.2013.05.029_bb0545","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12264-013-1310-6","article-title":"One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death","volume":"29","author":"Chen","year":"2013","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jns.2013.05.029_bb0550","doi-asserted-by":"crossref","first-page":"e57808","DOI":"10.1371\/journal.pone.0057808","article-title":"Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage","volume":"8","author":"Brewster","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2013.05.029_bb0555","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0560","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2011.12.051","article-title":"Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy","volume":"509","author":"Sliwa","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2013.05.029_bb0565","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/jcbfm.2011.131","article-title":"Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice","volume":"32","author":"Park","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2013.05.029_bb0570","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4161\/auto.6.3.11261","article-title":"Activation of autophagy and Akt\/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia\u2013ischemia","volume":"6","author":"Carloni","year":"2010","journal-title":"Autophagy"},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2013.05.029_bb0575","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1528-1167.2010.02607.x","article-title":"Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling","volume":"51","author":"Sankar","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2013.05.029_bb0580","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1528-1167.2008.02004.x","article-title":"Epilepsy after head injury: an overview","volume":"50","author":"Lowenstein","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2013.05.029_bb0585","doi-asserted-by":"crossref","first-page":"e39152","DOI":"10.1371\/journal.pone.0039152","article-title":"Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy","volume":"7","author":"Sha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2013.05.029_bb0590","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2012.09.019","article-title":"mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy","volume":"69","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2013.05.029_bb0595","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-8-14","article-title":"Comparison of three rapamycin dosing schedules in A\/J Tsc2+\/\u2212 mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors","volume":"8","author":"Woodrum","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0600","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1535-7163.MCT-10-0792","article-title":"Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens","volume":"10","author":"Rivera","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jns.2013.05.029_bb0605","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","article-title":"Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse","volume":"18","author":"Way","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0610","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0615","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/cercor\/bhr300","article-title":"GABAergic interneuron development and function is modulated by the Tsc1 gene","volume":"22","author":"Fu","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.jns.2013.05.029_bb0620","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","article-title":"Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis","volume":"96","author":"Waltereit","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2013.05.029_bb0625","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1460-9568.2006.04594.x","article-title":"Impaired synaptic plasticity in a rat model of tuberous sclerosis","volume":"23","author":"von der Brelie","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jns.2013.05.029_bb0630","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0387-7604(01)00300-X","article-title":"Infantile spasms in tuberous sclerosis complex","volume":"23","author":"Curatolo","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.jns.2013.05.029_bb0635","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.molmed.2011.07.008","article-title":"mTOR: a pathogenic signaling pathway in developmental brain malformations","volume":"17","author":"Crino","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jns.2013.05.029_bb0640","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jmg.2011.088807","article-title":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features","volume":"48","author":"Pilarski","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0645","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/brain\/awm100","article-title":"Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5","volume":"130","author":"Puffenberger","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2013.05.029_bb0650","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI41592","article-title":"STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice","volume":"120","author":"Orlova","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2013.05.029_bb0655","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1097-4547(19980815)53:4<502::AID-JNR13>3.0.CO;2-3","article-title":"Seizure activity induces PIM-1 expression in brain","volume":"53","author":"Feldman","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2013.05.029_bb0660","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/CIRCULATIONAHA.105.598409","article-title":"Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2013.05.029_bb0665","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hipo.20887","article-title":"Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function","volume":"22","author":"Balu","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.jns.2013.05.029_bb0670","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jns.2013.05.029_bb0675","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase Bgamma in attainment of normal brain size","volume":"25","author":"Easton","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jns.2013.05.029_bb0680","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/hmg\/ddq544","article-title":"A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice","volume":"20","author":"Tokuda","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2013.05.029_bb0685","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2008.07.010","article-title":"Dynamic seizure-related changes in extracellular signal-regulated kinase activation in a mouse model of temporal lobe epilepsy","volume":"156","author":"Houser","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2013.05.029_bb0690","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1471-4159.2008.05508.x","article-title":"Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus","volume":"106","author":"Lugo","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2013.05.029_bb0695","article-title":"Fetal brain mTOR signaling activation in tuberous sclerosis complex","author":"Tsai","year":"2013","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.jns.2013.05.029_bb0700","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4255\/mcpharmacol.09.16","article-title":"Developing antiepileptogenic drugs for acquired epilepsy: targeting the mammalian target of rapamycin (mTOR) pathway","volume":"1","author":"Zeng","year":"2009","journal-title":"Mol Cell Pharmacol"},{"key":"10.1016\/j.jns.2013.05.029_bb0705","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2012.02.143","article-title":"Rapamycin suppresses the recurrent excitatory circuits of dentate gyrus in a mouse model of temporal lobe epilepsy","volume":"420","author":"Tang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jns.2013.05.029_bb0710","doi-asserted-by":"crossref","first-page":"e35885","DOI":"10.1371\/journal.pone.0035885","article-title":"The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway","volume":"7","author":"Talos","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13002554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13002554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T04:21:16Z","timestamp":1539577276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13002554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":142,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022510X13002554"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.05.029","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the mTOR signaling pathway in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}